Research Paper Volume 15, Issue 16 pp 8471—8486
Tumor-derived exosomes RNA expression profiling identifies the prognosis, immune characteristics, and treatment in HR+/HER2-breast cancer
Figure 5. The ES predicting the sensitivity to chemosensitivity and endocrine therapy. Scatter plots for associations between drug sensitivity values (IC50) and (A) vincristine, (B) paclitaxel.